A Retrospective Review of the Use of Regional Citrate Anticoagulation in Continuous Venovenous Hemofiltration for Critically Ill Patients

Table 1

Patients’ characteristics.

		IRQ (interquartile range)
No. of patients included	44
No. of treatment episodes	56
Age (yr) (median)	64.0	57.5–74.5
Gender
Female	14
Male	30
Body weight (Kg) (median)	55.5	51.6–60
APACHE II score (median)	29.0	24.8–33.0
APACHE IV score (median)	101.5	79.3–125.3
No. of patients with comorbidities	36
DM	25
HT	30
IHD	6
ESRF	11
Reasons for starting dialysis
Sepsis	34
Fluid overload	10
Major surgery	6
Prerenal	3
Others	3
Baseline blood parameters
pH (median)	7.35	7.25–7.42
Base excess (median)	−4.5	−9.0 to −2.0
Sodium level (mmol/L, median)	137.5	136–141.8
Potassium level (mmol/L, median)	4.2	3.6–5.1
Phosphate level (mmol/L, median)	1.68	1.30–2.42
Magnesium level (mmol/L, median)	0.87	0.71–0.95
iCa (mmol/L, median)	1.08	0.96–1.14
Total Ca (mmol/L, median)	1.99	1.87–2.10
Urea (umol/L, median)	22.9	17.3–32.2
Creatinine (mmol/L, median)	398.5	284.0–616.8